Page 72 - BH-2-1
P. 72

Brain & Heart                                                     Mesenchymal cell therapy for heart disease



            22.  Zhu W, Huang L, Li Y, et al. Exosomes derived from human   32.  Zhang C, Zhou G, Chen Y,  et al. Human umbilical cord
               bone marrow mesenchymal stem cells promote tumor   mesenchymal stem cells alleviate interstitial fibrosis and
               growth in vivo. Cancer Lett. 2012;315(1):28-37.    cardiac  dysfunction in  a  dilated  cardiomyopathy  rat
                                                                  model by inhibiting TNF-α and TGF-β1/ERK1/2 signaling
               doi: 10.1016/j.canlet.2011.10.002
                                                                  pathways. Mol Med Rep. 2018;17(1):71-78.
            23.  Tomasoni S, Longaretti L, Rota C,  et al. Transfer of
               growth  factor  receptor  mRNA  via  exosomes  unravels  the      doi: 10.3892/mmr.2017.7882
               regenerative effect of mesenchymal stem cells.  Stem Cells   33.  Ciszek B, Skubiszewska D, Ratajska A. The anatomy of the
               Dev. 2013;22(5):772-780.                           cardiac veins in mice. J Anat. 2007;211(1):53-63.
               doi: 10.1089/scd.2012.0266                         doi: 10.1111/j.1469-7580.2007.00753.x
            24.  Yu B, Gong M, Wang Y, et al. Cardiomyocyte protection by   34.  Price  MJ,  Chou  CC,  Frantzen  M,  et  al.  Intravenous
               GATA-4 gene engineered mesenchymal stem cells is partially   mesenchymal stem cell therapy early after reperfused acute
               mediated by  translocation of  miR-221  in microvesicles.   myocardial infarction improves left ventricular function
               PLoS One. 2013;8(8):e73304.                        and alters electrophysiologic properties.  Int  J  Cardiol.
                                                                  2006;111(2):231-239.
               doi: 10.1371/journal.pone.0073304
                                                                  doi: 10.1016/j.ijcard.2005.07.036
            25.  Huang P, Wang L, Li Q, et al. Combinatorial treatment of
               acute myocardial infarction using stem cells and their   35.  Qi CM, Ma GS, Liu NF, et al. Transplantation of magnetically
               derived exosomes resulted in improved heart performance.   labeled mesenchymal stem cells improves cardiac function
               Stem Cell Res Ther. 2019;10(1):300.                in a swine myocardial infarction model. Chin Med J (Engl).
                                                                  2008;121(6):544-550.
               doi: 10.1186/s13287-019-1353-3
                                                                  doi: 10.1097/00029330-200803020-00016
            26.  Zlatanova I, Pinto C, Silvestre JS. Immune modulation of
                                                                                        rd
               cardiac repair and regeneration: The art of mending broken   36.  Hamamoto H, Gorman JH 3 , Ryan LP,  et al. Allogeneic
               hearts. Front Cardiovasc Med. 2016;3:40.           mesenchymal precursor cell therapy to limit remodeling
                                                                  after myocardial infarction: The effect of cell dosage. Ann
               doi: 10.3389/fcvm.2016.00040                       Thorac Surg. 2009;87(3):794-801.
            27.  Van Den Akker F, De Jager SCA, Sluijter JPG.      doi: 10.1016/j.athoracsur.2008.11.057
               Mesenchymal stem cell therapy for cardiac inflammation:
               Immunomodulatory properties and the influence of toll-like   37.  Karantalis V, Difede DL, Gerstenblith G, et al. Autologous
               receptors. Mediators Inflamm. 2013;2013:181020.    mesenchymal stem cells produce concordant improvements
                                                                  in regional function, tissue perfusion, and fibrotic burden
               doi: 10.1155/2013/181020                           when administered to patients undergoing coronary
            28.  Lee RH, Pulin AA, Seo MJ, et al. Intravenous hMSCs improve   artery bypass grafting: The prospective randomized study
               myocardial infarction in mice because cells embolized in   of mesenchymal stem cell therapy in patients undergoing
               lung are activated to secrete the anti-inflammatory protein   cardiac surgery (PROMETHEUS) trial.  Circ Res.
               TSG-6. Cell Stem Cell. 2009;5(1):54-63.            2014;114(8):1302-1310.
               doi: 10.1016/j.stem.2009.05.003                    doi: 10.1161/CIRCRESAHA.114.303180
            29.  Lemcke H, Voronina N, Steinhoff G, David R. Recent   38.  Florea V, Rieger AC, DiFede DL,  et al. Dose comparison
               progress in stem cell modification for cardiac regeneration.   study of allogeneic mesenchymal stem cells in patients with
               Stem Cells Int. 2018;2018:1909346.                 ischemic cardiomyopathy (The TRIDENT study). Circ Res.
                                                                  2017;121(11):1279-1290.
               doi: 10.1155/2018/1909346
                                                                  doi: 10.1161/CIRCRESAHA.117.311827
            30.  Orlic D, Kajstura J, Chimenti S, Dm B, Leri A, Anversa P.
               Bone marrow stem cells regenerate infarcted myocardium.   39.  Breitbach M, Bostani T, Roell W, et al. Potential risks of bone
               Pediatr Transplant. 2003;7:86-88.                  marrow  cell  transplantation  into  infarcted  hearts.  Blood.
                                                                  2007;110(4):1362-1369.
               doi: 10.1034/j.1399-3046.7.s3.13.x
                                                                  doi: 10.1182/blood-2006-12-063412
            31.  Mu Y, Cao G, Zeng Q, Li Y. Transplantation of induced
               bone marrow mesenchymal stem cells improves the   40.  Lin CS, Xin ZC, Dai J, Lue TF. Commonly used mesenchymal
               cardiac function of rabbits with dilated cardiomyopathy   stem cell markers and tracking labels: Limitations and
               via upregulation of vascular endothelial growth factor and   challenges. Histol Histopathol. 2013;28(9):1109-1116.
               its receptors. Exp Biol Med (Maywood). 2011;236(9):1100-     doi: 10.14670/HH-28.1109
               1107.
                                                               41.  Kandala J, Upadhyay GA, Pokushalov E, Wu S, Drachman DE,
               doi: 10.1258/ebm.2011.011066                       Singh JP. Meta-analysis of stem cell therapy in chronic


            Volume 2 Issue 1 (2024)                         6                         https://doi.org/10.36922/bh.2065
   67   68   69   70   71   72   73   74   75   76   77